

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.82579698 |
| 2 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.61405802 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.50809960 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.50809960 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.50809960 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.50809960 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.50809960 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.50809960 |
| 9 | basement membrane organization (GO:0071711) | 4.34591044 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.29489506 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.29489506 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.13130740 |
| 13 | apoptotic cell clearance (GO:0043277) | 3.88926873 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.88895634 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.86245334 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.79625816 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.77987246 |
| 18 | cellular extravasation (GO:0045123) | 3.72612997 |
| 19 | negative regulation of phagocytosis (GO:0050765) | 3.58910826 |
| 20 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.56067899 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.52402587 |
| 22 | detection of other organism (GO:0098543) | 3.50457525 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 3.48783410 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.46112884 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.43992122 |
| 26 | protein heterotrimerization (GO:0070208) | 3.40461888 |
| 27 | regulation of mast cell degranulation (GO:0043304) | 3.38987899 |
| 28 | leukocyte aggregation (GO:0070486) | 3.37545307 |
| 29 | detection of bacterium (GO:0016045) | 3.35418466 |
| 30 | chondrocyte proliferation (GO:0035988) | 3.34931588 |
| 31 | positive regulation of interferon-alpha production (GO:0032727) | 3.34202802 |
| 32 | endodermal cell differentiation (GO:0035987) | 3.33006636 |
| 33 | phagocytosis, recognition (GO:0006910) | 3.29093925 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24358966 |
| 35 | response to interferon-alpha (GO:0035455) | 3.21447499 |
| 36 | collagen fibril organization (GO:0030199) | 3.18811080 |
| 37 | * regulation of B cell receptor signaling pathway (GO:0050855) | 3.17356173 |
| 38 | axon extension involved in axon guidance (GO:0048846) | 3.16808532 |
| 39 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.16808532 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.15096789 |
| 41 | hyaluronan catabolic process (GO:0030214) | 3.14635428 |
| 42 | keratan sulfate catabolic process (GO:0042340) | 3.14567286 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.14402747 |
| 44 | pinocytosis (GO:0006907) | 3.11950025 |
| 45 | granulocyte activation (GO:0036230) | 3.11220032 |
| 46 | wound healing, spreading of epidermal cells (GO:0035313) | 3.11108235 |
| 47 | neutrophil activation (GO:0042119) | 3.10056735 |
| 48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.09558648 |
| 49 | regulation of T cell tolerance induction (GO:0002664) | 3.08607052 |
| 50 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.07600581 |
| 51 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.05359086 |
| 52 | positive regulation of B cell differentiation (GO:0045579) | 3.04458256 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 3.03024656 |
| 54 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02454416 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01299560 |
| 56 | regulation of leukocyte degranulation (GO:0043300) | 3.00591836 |
| 57 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.00577884 |
| 58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00097931 |
| 59 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.99731966 |
| 60 | myeloid cell activation involved in immune response (GO:0002275) | 2.97304822 |
| 61 | regulation of mononuclear cell migration (GO:0071675) | 2.96696674 |
| 62 | endothelium development (GO:0003158) | 2.93686047 |
| 63 | cell adhesion mediated by integrin (GO:0033627) | 2.93678402 |
| 64 | skin morphogenesis (GO:0043589) | 2.93346810 |
| 65 | positive thymic T cell selection (GO:0045059) | 2.92208438 |
| 66 | collagen metabolic process (GO:0032963) | 2.92069413 |
| 67 | blood vessel maturation (GO:0001955) | 2.91960541 |
| 68 | substrate-dependent cell migration (GO:0006929) | 2.89313275 |
| 69 | detection of biotic stimulus (GO:0009595) | 2.88493383 |
| 70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.87004278 |
| 71 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.87004278 |
| 72 | positive regulation of mast cell activation (GO:0033005) | 2.85958667 |
| 73 | collagen catabolic process (GO:0030574) | 2.84699414 |
| 74 | tolerance induction (GO:0002507) | 2.84587876 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 2.83333165 |
| 76 | response to peptidoglycan (GO:0032494) | 2.81566564 |
| 77 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.80893571 |
| 78 | myeloid dendritic cell differentiation (GO:0043011) | 2.79883953 |
| 79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79700380 |
| 80 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.78446903 |
| 81 | regulation of tolerance induction (GO:0002643) | 2.77902141 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77563690 |
| 83 | T cell migration (GO:0072678) | 2.77073916 |
| 84 | phagocytosis, engulfment (GO:0006911) | 2.75661140 |
| 85 | negative thymic T cell selection (GO:0045060) | 2.75555023 |
| 86 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.75070204 |
| 87 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.73085785 |
| 88 | lymph vessel development (GO:0001945) | 2.72162720 |
| 89 | regulation of B cell differentiation (GO:0045577) | 2.71844633 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.71451952 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 2.71451952 |
| 92 | amino sugar catabolic process (GO:0046348) | 2.71051913 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69481930 |
| 94 | response to host immune response (GO:0052572) | 2.69481930 |
| 95 | response to type I interferon (GO:0034340) | 2.69357483 |
| 96 | regulation of macrophage cytokine production (GO:0010935) | 2.68981668 |
| 97 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68658358 |
| 98 | regulation of monocyte chemotaxis (GO:0090025) | 2.68595030 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68533545 |
| 100 | regulation of mast cell activation (GO:0033003) | 2.67779241 |
| 101 | endothelial cell morphogenesis (GO:0001886) | 2.66805869 |
| 102 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.66703548 |
| 103 | negative regulation of innate immune response (GO:0045824) | 2.66351222 |
| 104 | B cell mediated immunity (GO:0019724) | 2.65995075 |
| 105 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.65311611 |
| 106 | immunoglobulin mediated immune response (GO:0016064) | 2.65205026 |
| 107 | type I interferon signaling pathway (GO:0060337) | 2.65177099 |
| 108 | cellular response to type I interferon (GO:0071357) | 2.65177099 |
| 109 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64398728 |
| 110 | response to host (GO:0075136) | 2.64398728 |
| 111 | response to host defenses (GO:0052200) | 2.64398728 |
| 112 | macrophage activation (GO:0042116) | 2.61616465 |
| 113 | response to muramyl dipeptide (GO:0032495) | 2.61304565 |
| 114 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.61244863 |
| 115 | lymphangiogenesis (GO:0001946) | 2.60696021 |
| 116 | endothelial tube morphogenesis (GO:0061154) | 2.59553655 |
| 117 | morphogenesis of an endothelium (GO:0003159) | 2.59553655 |
| 118 | negative T cell selection (GO:0043383) | 2.59373897 |
| 119 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.58886348 |
| 120 | cellular response to interferon-alpha (GO:0035457) | 2.58727692 |
| 121 | cell migration involved in heart development (GO:0060973) | 2.57704158 |
| 122 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.57106701 |
| 123 | cell proliferation involved in metanephros development (GO:0072203) | 2.56895281 |
| 124 | positive regulation of interleukin-2 production (GO:0032743) | 2.56800266 |
| 125 | extracellular matrix disassembly (GO:0022617) | 2.56623712 |
| 126 | response to fluid shear stress (GO:0034405) | 2.56486294 |
| 127 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.56367207 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.56097022 |
| 129 | angiogenesis involved in wound healing (GO:0060055) | 2.55751917 |
| 130 | fibril organization (GO:0097435) | 2.55250760 |
| 131 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54887635 |
| 132 | multicellular organismal catabolic process (GO:0044243) | 2.54674267 |
| 133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.53805600 |
| 134 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.53548854 |
| 135 | dermatan sulfate biosynthetic process (GO:0030208) | 2.53449172 |
| 136 | regulation of integrin activation (GO:0033623) | 2.52640756 |
| 137 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52199030 |
| 138 | positive regulation of antigen processing and presentation (GO:0002579) | 2.52132570 |
| 139 | microglial cell activation (GO:0001774) | 2.52021343 |
| 140 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.51619479 |
| 141 | myeloid leukocyte activation (GO:0002274) | 2.50301939 |
| 142 | dermatan sulfate metabolic process (GO:0030205) | 2.49384160 |
| 143 | response to laminar fluid shear stress (GO:0034616) | 2.49380288 |
| 144 | wound healing, spreading of cells (GO:0044319) | 2.47935612 |
| 145 | regulation of cholesterol storage (GO:0010885) | 2.47909988 |
| 146 | multicellular organismal metabolic process (GO:0044236) | 2.46227622 |
| 147 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.45851021 |
| 148 | endothelial cell proliferation (GO:0001935) | 2.45056522 |
| 149 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.44515591 |
| 150 | barbed-end actin filament capping (GO:0051016) | 2.44264694 |
| 151 | low-density lipoprotein particle clearance (GO:0034383) | 2.41208594 |
| 152 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.41013841 |
| 153 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.40688513 |
| 154 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.40474900 |
| 155 | response to interferon-beta (GO:0035456) | 2.39428741 |
| 156 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.39328506 |
| 157 | respiratory burst (GO:0045730) | 2.38745301 |
| 158 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38600218 |
| 159 | positive regulation of vasculogenesis (GO:2001214) | 2.37924553 |
| 160 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.36285929 |
| 161 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.35048705 |
| 162 | adhesion of symbiont to host (GO:0044406) | 2.34945848 |
| 163 | positive regulation of macrophage cytokine production (GO:0060907) | 2.34392266 |
| 164 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.32408752 |
| 165 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.31286845 |
| 166 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.30823639 |
| 167 | glomerular basement membrane development (GO:0032836) | 2.29960003 |
| 168 | negative regulation of fatty acid transport (GO:2000192) | 2.27032984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.83815814 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.06967797 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.67792763 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.65762674 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.54271652 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.51526927 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.32120564 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.21113555 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.87128700 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79337573 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.64660317 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62938005 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.53510248 |
| 14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.49051469 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.47926695 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.43452264 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37961748 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.35324960 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29845293 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.25739522 |
| 21 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.22259674 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.21723082 |
| 23 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.17028438 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09733724 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03783302 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91329443 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.84953788 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84057028 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82700467 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82491935 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78742660 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78331092 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76297157 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74062685 |
| 35 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.73994554 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72741046 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.71425643 |
| 38 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.70629069 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67899700 |
| 40 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66281007 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65677766 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64801467 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63775375 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63660259 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.55963344 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51143312 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.50754262 |
| 48 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.50621351 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.49748896 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48570885 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48561609 |
| 52 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48434086 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47970348 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46515147 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.45789490 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.45781275 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41911063 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38942769 |
| 59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38547091 |
| 60 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.34143581 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33505112 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33385573 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31677086 |
| 64 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30984436 |
| 65 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30984436 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30644727 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29659347 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28189728 |
| 69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27958016 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27691371 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27584923 |
| 72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25129475 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25054137 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24339253 |
| 75 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23745108 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23450814 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23377386 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22997854 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22730868 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21697148 |
| 81 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21652262 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21627093 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21556291 |
| 84 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.20345317 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20080320 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19932400 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19912404 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17206980 |
| 89 | MYC_22102868_ChIP-Seq_BL_Human | 1.17192067 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17021359 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16105650 |
| 92 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13777643 |
| 93 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13663029 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13450008 |
| 95 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12222547 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11879282 |
| 97 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11852707 |
| 98 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.10108772 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09075624 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08787443 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08520891 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07931402 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07590259 |
| 104 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.07157691 |
| 105 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06910016 |
| 106 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06596124 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06308793 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06048159 |
| 109 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05085428 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04957953 |
| 111 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03770992 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02708466 |
| 113 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02528820 |
| 114 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02184683 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01933193 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01871147 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01508613 |
| 118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00265339 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99492510 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99307592 |
| 121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98669719 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98520062 |
| 123 | * MYB_26560356_Chip-Seq_TH2_Human | 0.98230940 |
| 124 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97144626 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96412285 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95902272 |
| 127 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94989270 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94592550 |
| 129 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94023386 |
| 130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93540712 |
| 131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93104889 |
| 132 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92728152 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92241210 |
| 134 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91902445 |
| 135 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86819206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.44478394 |
| 2 | MP0006054_spinal_hemorrhage | 3.38740332 |
| 3 | MP0003279_aneurysm | 3.28843458 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.24226786 |
| 5 | MP0010368_abnormal_lymphatic_system | 2.84132335 |
| 6 | MP0005503_abnormal_tendon_morphology | 2.68394807 |
| 7 | MP0004272_abnormal_basement_membrane | 2.67765315 |
| 8 | MP0001879_abnormal_lymphatic_vessel | 2.55245903 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.52569211 |
| 10 | MP0005275_abnormal_skin_tensile | 2.49076810 |
| 11 | MP0001958_emphysema | 2.41567012 |
| 12 | MP0003436_decreased_susceptibility_to | 1.98066019 |
| 13 | MP0001835_abnormal_antigen_presentation | 1.96214298 |
| 14 | MP0003566_abnormal_cell_adhesion | 1.94007439 |
| 15 | MP0000343_altered_response_to | 1.90873617 |
| 16 | MP0003303_peritoneal_inflammation | 1.83640818 |
| 17 | MP0000767_abnormal_smooth_muscle | 1.79403217 |
| 18 | MP0001533_abnormal_skeleton_physiology | 1.79300095 |
| 19 | MP0002419_abnormal_innate_immunity | 1.74074618 |
| 20 | MP0005023_abnormal_wound_healing | 1.65548017 |
| 21 | MP0003724_increased_susceptibility_to | 1.64234027 |
| 22 | MP0000604_amyloidosis | 1.61694858 |
| 23 | MP0003690_abnormal_glial_cell | 1.61124741 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.57175527 |
| 25 | MP0000716_abnormal_immune_system | 1.57111296 |
| 26 | MP0006082_CNS_inflammation | 1.56195898 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.55182619 |
| 28 | MP0008260_abnormal_autophagy | 1.54704224 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.53241017 |
| 30 | MP0002398_abnormal_bone_marrow | 1.52113265 |
| 31 | MP0005508_abnormal_skeleton_morphology | 1.49969151 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.49168659 |
| 33 | MP0005390_skeleton_phenotype | 1.48545440 |
| 34 | MP0009278_abnormal_bone_marrow | 1.46450290 |
| 35 | MP0002998_abnormal_bone_remodeling | 1.46133824 |
| 36 | MP0003828_pulmonary_edema | 1.43866841 |
| 37 | MP0009785_altered_susceptibility_to | 1.41464414 |
| 38 | MP0003448_altered_tumor_morphology | 1.41266099 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.41021603 |
| 40 | MP0000685_abnormal_immune_system | 1.39179279 |
| 41 | MP0001542_abnormal_bone_strength | 1.36797462 |
| 42 | MP0002933_joint_inflammation | 1.33797821 |
| 43 | MP0003091_abnormal_cell_migration | 1.33633976 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.33062781 |
| 45 | MP0009840_abnormal_foam_cell | 1.32958757 |
| 46 | MP0000858_altered_metastatic_potential | 1.32510470 |
| 47 | MP0002429_abnormal_blood_cell | 1.32414672 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.32343648 |
| 49 | MP0001853_heart_inflammation | 1.32336772 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.31520310 |
| 51 | MP0002722_abnormal_immune_system | 1.28246257 |
| 52 | MP0001915_intracranial_hemorrhage | 1.28220603 |
| 53 | MP0005025_abnormal_response_to | 1.26726793 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.25693337 |
| 55 | MP0005164_abnormal_response_to | 1.24839549 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.24816357 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.24640568 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.22980511 |
| 59 | MP0004510_myositis | 1.19081629 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.19045092 |
| 61 | MP0000733_abnormal_muscle_development | 1.17844348 |
| 62 | MP0001849_ear_inflammation | 1.15311953 |
| 63 | MP0000249_abnormal_blood_vessel | 1.15302839 |
| 64 | MP0004883_abnormal_blood_vessel | 1.15052032 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.11792400 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.10703287 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.10172798 |
| 68 | MP0002132_abnormal_respiratory_system | 1.08849079 |
| 69 | MP0005387_immune_system_phenotype | 1.07017387 |
| 70 | MP0001790_abnormal_immune_system | 1.07017387 |
| 71 | MP0003385_abnormal_body_wall | 1.06882778 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.06653341 |
| 73 | MP0002405_respiratory_system_inflammati | 1.05423048 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 1.03230590 |
| 75 | MP0001243_abnormal_dermal_layer | 1.02295023 |
| 76 | MP0002060_abnormal_skin_morphology | 1.02091239 |
| 77 | MP0002128_abnormal_blood_circulation | 1.01191921 |
| 78 | MP0001614_abnormal_blood_vessel | 0.99844453 |
| 79 | MP0002282_abnormal_trachea_morphology | 0.98034622 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.97265587 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.97090350 |
| 82 | MP0000750_abnormal_muscle_regeneration | 0.95974189 |
| 83 | MP0003795_abnormal_bone_structure | 0.94507654 |
| 84 | MP0002396_abnormal_hematopoietic_system | 0.94252515 |
| 85 | MP0001819_abnormal_immune_cell | 0.91683215 |
| 86 | MP0001851_eye_inflammation | 0.90790622 |
| 87 | MP0002420_abnormal_adaptive_immunity | 0.90361681 |
| 88 | MP0001175_abnormal_lung_morphology | 0.90083613 |
| 89 | MP0002723_abnormal_immune_serum | 0.89644139 |
| 90 | MP0005166_decreased_susceptibility_to | 0.87853279 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 0.87427767 |
| 92 | MP0002113_abnormal_skeleton_development | 0.86383110 |
| 93 | MP0002115_abnormal_skeleton_extremities | 0.84995351 |
| 94 | MP0001800_abnormal_humoral_immune | 0.84361863 |
| 95 | MP0010030_abnormal_orbit_morphology | 0.84277408 |
| 96 | MP0004947_skin_inflammation | 0.84010235 |
| 97 | MP0003045_fibrosis | 0.83469822 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.83370139 |
| 99 | MP0001545_abnormal_hematopoietic_system | 0.83370139 |
| 100 | MP0005451_abnormal_body_composition | 0.83221730 |
| 101 | MP0009763_increased_sensitivity_to | 0.82996169 |
| 102 | MP0000490_abnormal_crypts_of | 0.82795236 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.82760038 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.82355619 |
| 105 | MP0009250_abnormal_appendicular_skeleto | 0.81693726 |
| 106 | MP0003075_altered_response_to | 0.80457413 |
| 107 | MP0005165_increased_susceptibility_to | 0.80180392 |
| 108 | MP0009764_decreased_sensitivity_to | 0.80070543 |
| 109 | MP0005310_abnormal_salivary_gland | 0.79710753 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.79183240 |
| 111 | MP0001663_abnormal_digestive_system | 0.78367935 |
| 112 | MP0008004_abnormal_stomach_pH | 0.76930440 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.76877190 |
| 114 | MP0002089_abnormal_postnatal_growth/wei | 0.75146399 |
| 115 | MP0002925_abnormal_cardiovascular_devel | 0.75067953 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.73644657 |
| 117 | MP0008469_abnormal_protein_level | 0.72395998 |
| 118 | MP0000428_abnormal_craniofacial_morphol | 0.71569540 |
| 119 | MP0005671_abnormal_response_to | 0.71388581 |
| 120 | MP0000163_abnormal_cartilage_morphology | 0.71221558 |
| 121 | MP0008007_abnormal_cellular_replicative | 0.70967965 |
| 122 | MP0003866_abnormal_defecation | 0.70904306 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.69840993 |
| 124 | MP0004858_abnormal_nervous_system | 0.69139957 |
| 125 | MP0000678_abnormal_parathyroid_gland | 0.68862830 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.66468884 |
| 127 | MP0001873_stomach_inflammation | 0.64347760 |
| 128 | MP0002277_abnormal_respiratory_mucosa | 0.60882176 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.57229219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.03217717 |
| 2 | Premature rupture of membranes (HP:0001788) | 5.07996378 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.82042433 |
| 4 | Cervical subluxation (HP:0003308) | 3.81003799 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.76658984 |
| 6 | Aortic dissection (HP:0002647) | 3.76372564 |
| 7 | Vertebral compression fractures (HP:0002953) | 3.67309983 |
| 8 | Spondylolisthesis (HP:0003302) | 3.54097570 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.52388310 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.50097136 |
| 11 | Obstructive lung disease (HP:0006536) | 3.50097136 |
| 12 | Broad metatarsal (HP:0001783) | 3.44422453 |
| 13 | Stomatitis (HP:0010280) | 3.41016747 |
| 14 | Peritonitis (HP:0002586) | 3.38427764 |
| 15 | Ankle contracture (HP:0006466) | 3.34628102 |
| 16 | Shallow orbits (HP:0000586) | 3.34044732 |
| 17 | Aortic aneurysm (HP:0004942) | 3.24561894 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.23170292 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.18164649 |
| 20 | Soft skin (HP:0000977) | 3.15790107 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.14916607 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.12194911 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 3.10598289 |
| 24 | Amyloidosis (HP:0011034) | 3.09123746 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.02955655 |
| 26 | Optic neuritis (HP:0100653) | 3.02955655 |
| 27 | Increased IgE level (HP:0003212) | 2.98079325 |
| 28 | Recurrent skin infections (HP:0001581) | 2.86667701 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.86291201 |
| 30 | Dilatation of the ascending aorta (HP:0005111) | 2.82092423 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.81711551 |
| 32 | Vascular tortuosity (HP:0004948) | 2.81206974 |
| 33 | Nonimmune hydrops fetalis (HP:0001790) | 2.79481507 |
| 34 | Hematochezia (HP:0002573) | 2.78821297 |
| 35 | Blue sclerae (HP:0000592) | 2.78613380 |
| 36 | Meningitis (HP:0001287) | 2.78072249 |
| 37 | Osteolytic defects of the hand bones (HP:0009699) | 2.72877485 |
| 38 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.72877485 |
| 39 | Syringomyelia (HP:0003396) | 2.72051611 |
| 40 | Spinal cord lesions (HP:0100561) | 2.72051611 |
| 41 | Arterial tortuosity (HP:0005116) | 2.71010379 |
| 42 | Loss of speech (HP:0002371) | 2.70426974 |
| 43 | Gingivitis (HP:0000230) | 2.69337760 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.67850936 |
| 45 | Recurrent viral infections (HP:0004429) | 2.67653562 |
| 46 | Petechiae (HP:0000967) | 2.63072403 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.61701199 |
| 48 | Wormian bones (HP:0002645) | 2.59752330 |
| 49 | Vasculitis (HP:0002633) | 2.58293051 |
| 50 | Biconcave vertebral bodies (HP:0004586) | 2.58218480 |
| 51 | Disinhibition (HP:0000734) | 2.56125657 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.55771999 |
| 53 | Increased serum ferritin (HP:0003281) | 2.53488892 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.51762497 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.51689529 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.51689529 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.50094974 |
| 58 | Bladder diverticulum (HP:0000015) | 2.49958957 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.49010710 |
| 60 | Epistaxis (HP:0000421) | 2.46294177 |
| 61 | Abnormality of dentin (HP:0010299) | 2.45903519 |
| 62 | Encephalitis (HP:0002383) | 2.44733313 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.43920510 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43920510 |
| 65 | Mitral valve prolapse (HP:0001634) | 2.43352772 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.37375886 |
| 67 | Increased IgM level (HP:0003496) | 2.34530217 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.34157921 |
| 69 | Follicular hyperkeratosis (HP:0007502) | 2.33000297 |
| 70 | Hemoptysis (HP:0002105) | 2.32614132 |
| 71 | Thrombocytosis (HP:0001894) | 2.32007878 |
| 72 | Chest pain (HP:0100749) | 2.31645877 |
| 73 | Absent frontal sinuses (HP:0002688) | 2.29980222 |
| 74 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.28019835 |
| 75 | Spinal rigidity (HP:0003306) | 2.27108239 |
| 76 | Atrophic scars (HP:0001075) | 2.26358790 |
| 77 | Leukocytosis (HP:0001974) | 2.24604520 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.23532628 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.23144289 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.23144289 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.23144289 |
| 82 | Urticaria (HP:0001025) | 2.22129116 |
| 83 | Abnormality of the acetabulum (HP:0003170) | 2.22031365 |
| 84 | Wrist flexion contracture (HP:0001239) | 2.20058946 |
| 85 | Joint stiffness (HP:0001387) | 2.16963493 |
| 86 | Glomerulonephritis (HP:0000099) | 2.16632653 |
| 87 | Camptodactyly of toe (HP:0001836) | 2.15740802 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.14579575 |
| 89 | Myositis (HP:0100614) | 2.14457615 |
| 90 | Abnormality of the peritoneum (HP:0002585) | 2.14175784 |
| 91 | Lymphopenia (HP:0001888) | 2.13175348 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.10153480 |
| 93 | T lymphocytopenia (HP:0005403) | 2.09508269 |
| 94 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.08469660 |
| 95 | Fragile skin (HP:0001030) | 2.06571464 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.04316690 |
| 97 | Episodic fever (HP:0001954) | 2.04122231 |
| 98 | Gingival bleeding (HP:0000225) | 2.02867130 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02611733 |
| 100 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02611733 |
| 101 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02611733 |
| 102 | Premature loss of primary teeth (HP:0006323) | 2.01676275 |
| 103 | Pustule (HP:0200039) | 2.00687817 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 2.00401504 |
| 105 | Coxa vara (HP:0002812) | 2.00150265 |
| 106 | Axonal loss (HP:0003447) | 1.98808002 |
| 107 | Aneurysm (HP:0002617) | 1.97385480 |
| 108 | Flexion contracture of toe (HP:0005830) | 1.96376149 |
| 109 | Joint contractures involving the joints of the feet (HP:0100492) | 1.96376149 |
| 110 | Neonatal short-limb short stature (HP:0008921) | 1.95679896 |
| 111 | Gastrointestinal stroma tumor (HP:0100723) | 1.95012192 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.94986133 |
| 113 | Nuclear cataract (HP:0100018) | 1.94906071 |
| 114 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.93320864 |
| 115 | Asymmetry of the thorax (HP:0001555) | 1.93283982 |
| 116 | Restrictive lung disease (HP:0002091) | 1.92695015 |
| 117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92159296 |
| 118 | Slender build (HP:0001533) | 1.91650684 |
| 119 | Genu recurvatum (HP:0002816) | 1.91515463 |
| 120 | Granulocytopenia (HP:0001913) | 1.91017384 |
| 121 | Joint laxity (HP:0001388) | 1.90821539 |
| 122 | Ovoid vertebral bodies (HP:0003300) | 1.90332192 |
| 123 | Type 1 muscle fiber predominance (HP:0003803) | 1.89801891 |
| 124 | Basal ganglia calcification (HP:0002135) | 1.89675351 |
| 125 | Increased connective tissue (HP:0009025) | 1.89522367 |
| 126 | Abnormality of the pleura (HP:0002103) | 1.89268734 |
| 127 | Orchitis (HP:0100796) | 1.89258163 |
| 128 | Asymmetric septal hypertrophy (HP:0001670) | 1.88846471 |
| 129 | Global brain atrophy (HP:0002283) | 1.88711759 |
| 130 | Hypertensive crisis (HP:0100735) | 1.88507942 |
| 131 | Abnormality of skull ossification (HP:0002703) | 1.87027283 |
| 132 | Abnormality of T cell number (HP:0011839) | 1.86774485 |
| 133 | Emphysema (HP:0002097) | 1.86716099 |
| 134 | Elbow flexion contracture (HP:0002987) | 1.86477101 |
| 135 | Abnormality of the lumbar spine (HP:0100712) | 1.86446794 |
| 136 | Delayed cranial suture closure (HP:0000270) | 1.86119126 |
| 137 | Short middle phalanx of the 5th finger (HP:0004220) | 1.85997603 |
| 138 | Beaking of vertebral bodies (HP:0004568) | 1.85355861 |
| 139 | Glomerulopathy (HP:0100820) | 1.84459527 |
| 140 | Gastrointestinal inflammation (HP:0004386) | 1.84262768 |
| 141 | Thin bony cortex (HP:0002753) | 1.84241703 |
| 142 | Keratoconjunctivitis (HP:0001096) | 1.84102946 |
| 143 | Purpura (HP:0000979) | 1.83565019 |
| 144 | Upper motor neuron abnormality (HP:0002127) | 1.83532623 |
| 145 | Poor head control (HP:0002421) | 1.83457909 |
| 146 | Pulmonary embolism (HP:0002204) | 1.83283331 |
| 147 | Mesangial abnormality (HP:0001966) | 1.83163150 |
| 148 | Short 4th metacarpal (HP:0010044) | 1.83144961 |
| 149 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.83144961 |
| 150 | Thoracic kyphosis (HP:0002942) | 1.83129053 |
| 151 | Polygenic inheritance (HP:0010982) | 1.81993492 |
| 152 | Arterial thrombosis (HP:0004420) | 1.80934258 |
| 153 | Acrocyanosis (HP:0001063) | 1.80031316 |
| 154 | Mediastinal lymphadenopathy (HP:0100721) | 1.79923561 |
| 155 | Striae distensae (HP:0001065) | 1.79908996 |
| 156 | Disproportionate tall stature (HP:0001519) | 1.79717016 |
| 157 | Radial bowing (HP:0002986) | 1.79190935 |
| 158 | Ulnar bowing (HP:0003031) | 1.77958387 |
| 159 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76946473 |
| 160 | Myocardial infarction (HP:0001658) | 1.75181933 |
| 161 | Cellulitis (HP:0100658) | 1.74257268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 3.89951386 |
| 2 | ERN1 | 3.84092023 |
| 3 | TRIB3 | 3.74998470 |
| 4 | TGFBR2 | 3.58674639 |
| 5 | TIE1 | 3.04364197 |
| 6 | PRPF4B | 2.77132954 |
| 7 | PKN2 | 2.63525354 |
| 8 | TGFBR1 | 2.48336855 |
| 9 | TBK1 | 2.20553400 |
| 10 | MAP3K13 | 2.15837738 |
| 11 | FES | 2.12591756 |
| 12 | TTN | 2.07081308 |
| 13 | NME2 | 2.05944739 |
| 14 | KIT | 2.04055164 |
| 15 | BLK | 2.02162046 |
| 16 | PIM2 | 1.97238754 |
| 17 | JAK3 | 1.92130581 |
| 18 | TYK2 | 1.91255148 |
| 19 | PRKD2 | 1.83252883 |
| 20 | RPS6KA4 | 1.81853998 |
| 21 | PTK6 | 1.81184171 |
| 22 | MAP2K3 | 1.80123573 |
| 23 | PAK4 | 1.74584874 |
| 24 | RIPK1 | 1.66130310 |
| 25 | PDGFRA | 1.65641820 |
| 26 | LRRK2 | 1.60692680 |
| 27 | BMX | 1.50101425 |
| 28 | TXK | 1.46963423 |
| 29 | DDR2 | 1.45261931 |
| 30 | NEK9 | 1.43371201 |
| 31 | IRAK3 | 1.40817947 |
| 32 | EPHB2 | 1.35787559 |
| 33 | TNK2 | 1.30668257 |
| 34 | MAP4K1 | 1.27890325 |
| 35 | IRAK4 | 1.22565565 |
| 36 | GRK6 | 1.19557358 |
| 37 | FLT3 | 1.18085494 |
| 38 | SYK | 1.17469359 |
| 39 | ZAP70 | 1.17000233 |
| 40 | IKBKB | 1.16571261 |
| 41 | MAP3K10 | 1.15602362 |
| 42 | CSF1R | 1.13867037 |
| 43 | PAK2 | 1.12563510 |
| 44 | PTK2B | 1.10877719 |
| 45 | GRK7 | 1.09720981 |
| 46 | VRK2 | 1.09085413 |
| 47 | ILK | 1.06881140 |
| 48 | TESK1 | 1.06839998 |
| 49 | MAP3K3 | 1.04577583 |
| 50 | STK10 | 1.03683740 |
| 51 | EPHB1 | 1.03322997 |
| 52 | TAOK1 | 1.01495050 |
| 53 | MAP3K14 | 0.98274724 |
| 54 | MET | 0.97823939 |
| 55 | ITK | 0.96287216 |
| 56 | JAK1 | 0.94667891 |
| 57 | LATS2 | 0.93533410 |
| 58 | SMG1 | 0.92897258 |
| 59 | MAP3K1 | 0.92885027 |
| 60 | MYLK | 0.92785075 |
| 61 | SCYL2 | 0.92393344 |
| 62 | SIK3 | 0.91557398 |
| 63 | CDC42BPA | 0.90915788 |
| 64 | BTK | 0.87820500 |
| 65 | TRPM7 | 0.87482979 |
| 66 | ABL2 | 0.86783214 |
| 67 | DMPK | 0.82180456 |
| 68 | RPS6KL1 | 0.81681009 |
| 69 | RPS6KC1 | 0.81681009 |
| 70 | MOS | 0.79174458 |
| 71 | IKBKE | 0.78804949 |
| 72 | HCK | 0.76546636 |
| 73 | PTK2 | 0.75998441 |
| 74 | PRKCH | 0.74679159 |
| 75 | EPHA3 | 0.73360685 |
| 76 | SIK1 | 0.73182370 |
| 77 | CDK6 | 0.72821981 |
| 78 | MAP3K11 | 0.72659421 |
| 79 | TAOK2 | 0.72286480 |
| 80 | CSK | 0.70148328 |
| 81 | MARK3 | 0.69584164 |
| 82 | CLK1 | 0.68990262 |
| 83 | MAP3K8 | 0.67737161 |
| 84 | STK3 | 0.66816433 |
| 85 | MAPK7 | 0.65428435 |
| 86 | PDGFRB | 0.64997153 |
| 87 | CHUK | 0.63313609 |
| 88 | LYN | 0.61851178 |
| 89 | MAPK12 | 0.60760573 |
| 90 | ERBB3 | 0.60237252 |
| 91 | TEC | 0.59436114 |
| 92 | CDK4 | 0.58646213 |
| 93 | CAMK1D | 0.56653275 |
| 94 | PDPK1 | 0.56584319 |
| 95 | MARK2 | 0.56073716 |
| 96 | HIPK2 | 0.55057908 |
| 97 | MST1R | 0.54899718 |
| 98 | RPS6KA2 | 0.54727780 |
| 99 | PRKG2 | 0.54412983 |
| 100 | TAOK3 | 0.53515367 |
| 101 | PDK1 | 0.53062009 |
| 102 | LATS1 | 0.52973572 |
| 103 | PIM1 | 0.52529544 |
| 104 | MAPKAPK2 | 0.51523563 |
| 105 | IGF1R | 0.51204683 |
| 106 | IRAK2 | 0.51129440 |
| 107 | EGFR | 0.50745971 |
| 108 | JAK2 | 0.49960706 |
| 109 | LCK | 0.48716436 |
| 110 | FGFR3 | 0.48634312 |
| 111 | ARAF | 0.48313742 |
| 112 | FGFR4 | 0.47812079 |
| 113 | MAP3K6 | 0.45940644 |
| 114 | ABL1 | 0.45720101 |
| 115 | TYRO3 | 0.44588254 |
| 116 | PAK1 | 0.44428317 |
| 117 | PBK | 0.43776738 |
| 118 | PIK3CG | 0.43425000 |
| 119 | MAP3K7 | 0.43321523 |
| 120 | FGR | 0.42486535 |
| 121 | MATK | 0.41905974 |
| 122 | RIPK4 | 0.41634103 |
| 123 | EEF2K | 0.41396325 |
| 124 | CDK7 | 0.40808102 |
| 125 | PRKCQ | 0.40125683 |
| 126 | SRC | 0.39943429 |
| 127 | RPS6KA6 | 0.39835901 |
| 128 | DAPK3 | 0.39403180 |
| 129 | FGFR1 | 0.38708040 |
| 130 | ICK | 0.37736480 |
| 131 | PRKD1 | 0.37736357 |
| 132 | IRAK1 | 0.37468697 |
| 133 | KSR2 | 0.36193730 |
| 134 | CDK8 | 0.36190467 |
| 135 | TESK2 | 0.36118551 |
| 136 | FER | 0.34863889 |
| 137 | ROCK1 | 0.34828264 |
| 138 | PRKCD | 0.34383736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.13807639 |
| 2 | Malaria_Homo sapiens_hsa05144 | 2.70909645 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64560525 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.47973406 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.42623688 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.36024288 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.15938387 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.13998178 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00070975 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96552977 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96489664 |
| 12 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.95857174 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.95684795 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.86758607 |
| 15 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.83127224 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.78813389 |
| 17 | Focal adhesion_Homo sapiens_hsa04510 | 1.73082589 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.71147463 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.64958100 |
| 20 | Shigellosis_Homo sapiens_hsa05131 | 1.64272851 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.55656148 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.53334127 |
| 23 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.52646007 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51491278 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51037386 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48193327 |
| 27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.47561673 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45120315 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.43363769 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42008264 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.41462491 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.40780236 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.38521174 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32814724 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.32770782 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30871327 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29057915 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24842493 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.20394967 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17593247 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15554733 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.14666382 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 1.13736001 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13159008 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12181564 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11205770 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10535153 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09172499 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.08908384 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08283408 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08249438 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06474687 |
| 53 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.06340169 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01470240 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00989726 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00911718 |
| 57 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.96615046 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96261631 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95673711 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92930981 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90133117 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89203468 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85447849 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84943639 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83116525 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.82959345 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80992617 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79030906 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78155031 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76947031 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75107903 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73909189 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73630277 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73246410 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73202041 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72845145 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71785364 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71019325 |
| 79 | Pathways in cancer_Homo sapiens_hsa05200 | 0.70492528 |
| 80 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68782981 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68195127 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.68163550 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68041603 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67910157 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65342136 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65221370 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64051913 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.63637799 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62498709 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62475578 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60992505 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60747731 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.60071470 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.58279926 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.57672411 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.57625320 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57605265 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56372193 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55652854 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54853351 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.54653968 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52771049 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52572761 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50746851 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50044139 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46973171 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45419848 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45184021 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43327700 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41361680 |
| 111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41104477 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41095794 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40231579 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39795397 |
| 115 | Ribosome_Homo sapiens_hsa03010 | 0.39268683 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38733876 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34744800 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32112678 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29778316 |

